@bill75331820 @tuduylinh $BLCM failed to deliver so far, even so they have a clinical-successful project (BPX-501, Rivo-Cel) on the shelf that is ready for EU-markets for almost a year. For BPX-601 see this recent market review https://t.co/yVyW2DTVVe
@ChristianHomsy @CelyadSA Well, I posted several reviews over time, included yours, @CelyadSA people, specifically on CAR-Ts in solid tumors, last year. In english, I think I'd have said "the first CAR-T EVER" if I had really meant "the first" as we say in
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
Hasta 1/3 de los ensayos con CAR-T se dirigen a neoplasias sólidas, aunque hay todavía quedan dificultades por solventar. #CAR-T https://t.co/aLeXc0vT2M
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
RT @BertrandBio: Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd http…
Landscape of CAR-Ts in solid tumors by $CYAD: targets, approaches, setting, list of trials... https://t.co/1ZzBrtRLBd https://t.co/FbFPDw5UlM
RT @Val_Invest_12: $blcm trading close to cash... mostly driven by financial situation and stock market traders... the science is still ver…
RT @Val_Invest_12: $blcm trading close to cash... mostly driven by financial situation and stock market traders... the science is still ver…
$blcm trading close to cash... mostly driven by financial situation and stock market traders... the science is still very interesting as stated in the recent review that just came out https://t.co/jsS9oLRjlV https://t.co/Cfg4otrheX